Therapeutics of Alzheimer's disease: Past, present and future

R Anand, KD Gill, AA Mahdi - Neuropharmacology, 2014 - Elsevier
Alzheimer's disease (AD) is the most common cause of dementia worldwide. The etiology is
multifactorial, and pathophysiology of the disease is complex. Data indicate an exponential …

Pathophysiology associated with traumatic brain injury: current treatments and potential novel therapeutics

ML Pearn, IR Niesman, J Egawa, A Sawada… - Cellular and molecular …, 2017 - Springer
Traumatic brain injury (TBI) is one of the leading causes of death of young people in the
developed world. In the United States alone, 1.7 million traumatic events occur annually …

LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature

U Ravnskov, M de Lorgeril, DM Diamond… - Expert review of …, 2018 - Taylor & Francis
Introduction: For half a century, a high level of total cholesterol (TC) or low-density
lipoprotein cholesterol (LDL-C) has been considered to be the major cause of …

Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials

BR Ott, LA Daiello, IJ Dahabreh, BA Springate… - Journal of general …, 2015 - Springer
ABSTRACT BACKGROUND In 2012, the United States Food and Drug Administration (FDA)
issued a warning regarding potential adverse effects of HMG-CoA reductase inhibitors …

Aggressive LDL-C lowering and the brain: impact on risk for dementia and hemorrhagic stroke: a scientific statement from the American Heart Association

LB Goldstein, PP Toth… - … and Vascular Biology, 2023 - Am Heart Assoc
The objective of this scientific statement is to evaluate contemporary evidence that either
supports or refutes the conclusion that aggressive low-density lipoprotein cholesterol …

[HTML][HTML] The role of NOX inhibitors in neurodegenerative diseases

S Barua, JY Kim, MA Yenari, JE Lee - IBRO reports, 2019 - Elsevier
Oxidative stress is a key player in both chronic and acute brain disease due to the higher
metabolic demand of the brain. Among the producers of free radicals, NADPH-oxidase …

Low-density lipoprotein cholesterol lowering treatment: the current approach

I Crismaru, A Pantea Stoian, OG Bratu… - Lipids in health and …, 2020 - Springer
In the last 50 years, several clinical and epidemiological studies during have shown that
increased levels of low-density lipoprotein cholesterol (LDLc) are associated with the …

An assessment by the statin cognitive safety task force: 2014 update

CH Rojas-Fernandez, LB Goldstein, AI Levey… - Journal of Clinical …, 2014 - Elsevier
Abstract The National Lipid Association's Safety Task Force convened a consensus
conference of experts to develop a position statement on cognitive function to revise and …

How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease

DM Diamond, U Ravnskov - Expert review of clinical pharmacology, 2015 - Taylor & Francis
We have provided a critical assessment of research on the reduction of cholesterol levels by
statin treatment to reduce cardiovascular disease. Our opinion is that although statins are …

Effects of statins on dopamine loss and prognosis in Parkinson's disease

SH Jeong, HS Lee, SJ Chung, HS Yoo, JH Jung… - Brain, 2021 - academic.oup.com
Statins are more widely used not only for the primary and secondary prevention of
cardiovascular disease by blocking cholesterol biosynthesis but also for the potential …